Reliability and agreement between alternative CO 2 paradigms for assessment of cerebrovascular reactivity in cerebral small vessel disease
Physiological Measurement · 2026
DOI: 10.1088/1361-6579/aeac99 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Physiological Measurement, 2026. Verfasst von Osian Llwyd und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, Wolfson Centre for Prevention of Stroke and Dementia, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Carbon Dioxide, Cerebral Small Vessel Diseases, Cerebrovascular Circulation. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stroke Association fellowship, Alzheimer’s Society, AJSW’s Wellcome Trust.
Abstract (Originalsprache)
Cerebrovascular reactivity (CVR) to CO 2 is increasingly used as an index of cerebrovascular health and function in trials in cerebral small vessel disease (CSVD). Further work is needed to determine the validity and optimal parameters of this technique. In 75 CSVD patients in the placebo-controlled, crossover OxHARP trial of sildenafil, agreement and reproducibility of baseline (1st visit) and placebo visit CVR was derived comparing 4% and 6% CO 2 exposure. Peak response to each dose was used to estimate CVR (Δ cerebral blood velocity/ Δ end-tidal CO 2 ) using absolute (cm.s –1 /etCO 2 %), fully standardised (%Δ/%Δ) or semi-standardised (%Δ/etCO 2 %) approaches, and compared to CVR from delay-shifted, beat-to-beat associations from general linear models (GLM). Single-point measurements showed less inter- and intra-participant variability. The 6% CO 2 prompted higher absolute and standardised CVR values, although this was not observed with the semi-standardised of analysis. CVR estimates using absolute values showed comparable inter- and intra-participant variability across CO 2 challenges. However, reproducibility improved when CVR values were standardised following exposure to 6% CO 2 or derived using GLM that incorporated data from both 4% and 6% CO 2 data. The strongest agreement between CVR methods was achieved with analyses using absolute values. CVR assessments were reproducible, but this reliability was influenced by CO 2 dose and the analytical approach. While single-point measurements showed the best inter- and intra-participant variability, overall, CVR estimation using a GLM demonstrated a superior test-retest reliability across visits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neurosciences, Wolfson Centre for Prevention of Stroke and Dementia, University of Oxford, Oxford, United Kingdom.
- Jackie Walton Vascular Studies Unit, John Radcliffe Hospital, Oxford, United Kingdom.
- School of Medicine, University of St Andrews, St Andrews, United Kingdom.
- Department of Brain Sciences, Imperial College London, London, United Kingdom.
ORCID-Profile: Osian Llwyd, Karolina Feakins
Förderung
- Stroke Association fellowship
- Alzheimer’s Society
- AJSW’s Wellcome Trust
Zitieren
APA
Llwyd, O., Feakins, K., Stewart, C., Thomas, J., & Webb, A. (2026). Reliability and agreement between alternative CO 2 paradigms for assessment of cerebrovascular reactivity in cerebral small vessel disease. Physiological Measurement. https://doi.org/10.1088/1361-6579/aeac99
Vancouver
Llwyd O, Feakins K, Stewart C, Thomas J, Webb A. Reliability and agreement between alternative CO 2 paradigms for assessment of cerebrovascular reactivity in cerebral small vessel disease. Physiological Measurement. 2026. doi:10.1088/1361-6579/aeac99
BibTeX
@article{Llwyd2026,
author = {Llwyd, Osian and Feakins, Karolina and Stewart, Catriona and Thomas, James and Webb, Alastair},
title = {Reliability and agreement between alternative CO 2 paradigms for assessment of cerebrovascular reactivity in cerebral small vessel disease},
journal = {Physiological Measurement},
year = {2026},
doi = {10.1088/1361-6579/aeac99}
}
EUVIMED